NCT02602353

Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)

A Phase 2, Randomized, Double-Blind, Parallel-Group and Placebo-Controlled Pilot Study to Assess the Safety and Efficacy of a New Pain Patch Versus Placebo and No Treatment for the Treatment of Delayed Onset Muscle Soreness (DOMS)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: Lead Chemical Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 40 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the analgesic efficacy and safety of a new pain patch compared to placebo and no treatment in subjects experiencing Delayed Onset Muscle Soreness (DOMS).

Conditions

• Delayed Onset Muscle Soreness

Interventions

Type	Name	Description
DRUG	Loxoprofen Pain Patch	One Loxoprofen Pain Patch (active NSAID) applied once daily for 3 days
DRUG	Placebo Patch	One Placebo Patch applied daily for 3 days
DRUG	No Treatment	No Treatment for 3 days

Timeline

• Start date: 2015-10-01
• Primary completion: 2015-12-01
• Completion: 2015-12-01
• First posted: 2015-11-11
• Last updated: 2016-10-28

Locations

1 site across 1 country: United States